Advertisement · 728 × 90

Posts by Pablo Garcia

We are thrilled to announce that we have generously received funding for a one-year hypertension fellowship, and we are recruiting now for a candidate to start fellowship July 1, 2026 .
med.stanford.edu/hypertension/e…

-Jehan Zahid Bahrainwala
HTN Fellowship Program Director

6 months ago 14 8 0 1
Kidney International Case Reports | Journal | ScienceDirect.com by Elsevier Read the latest articles of Kidney International Case Reports at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature

We are live

The @theisn.org launches a new journal

www.sciencedirect.com/journal/kidn...

4 months ago 32 12 4 1

My understanding is that Renasight is not available in Latin America, I might be wrong. It will be better to get it done in the US

5 months ago 2 0 0 0

OK thread of all simulpubs at this year's #KidneyWk

ORIGIN-3: Atacicept pubmed.ncbi.nlm.nih.gov/41196369/

CKD as a curable dz? www.kidney-international.org/article/S008...

Albuminuria as a surrogate endpoint www.nature.com/articles/s41...

5 months ago 11 5 2 0
Preview
Molecularly Targeted Cancer Medications and Kidney Health This cohort study evaluates the 2-year incidence and relative rates of progressive kidney dysfunction in patients treated with molecularly targeted cancer medications.

Is this considered a simultaneous publication?

Molecularly Targeted Cancer Medications and Kidney Health
jamanetwork.com/journals/jam...

www.asn-online.org/education/ki...

5 months ago 1 0 0 0
Post image

This is the APRIL inhibitors ASN Kidney Week

5 months ago 2 1 0 0
Post image

@nytimes.com has caused some misinformation re organ donation.
Here is a step by step of the real
WHO, WHAT, WHEN, WHY that actually goes into the process of organ donation!
@onelegacy.bsky.social
@ukrocharity.bsky.social
#transplant
#donatelife
#donors
#ukro

8 months ago 8 6 0 0
Post image

Here is a step by step of the
WHO, WHAT, WHEN, WHY that actually goes into the process of organ donation!
(While this is a US centric info graphic , similar processes are used around the globe)

#donationsaveslives
#transplantation

8 months ago 9 6 0 0
Post image

Recently @nytimes.com created some uproar with misreporting about the noble gift of life. I am an organ donor and a proud caregiver to transplant recipients. 91,869 patients are waiting for a kidney transplant & 50% would die before transplant due to organ shortage.Learn about it:
#donationsaveslife

8 months ago 12 6 1 0
Advertisement

🤣🤣

8 months ago 0 0 0 0
Video

I saw it in the same spot by CTSC, running away from a coyote 🐺

8 months ago 0 0 1 0

Perhaps @ajkd.bsky.social should create a nephropath attending or attending section. There are a few rheum attendings participating too #NephMadness

1 year ago 0 0 0 0

In the final score table @glombandit.bsky.social who is an attending, scored higher than @nephrowhitt.bsky.social #NephMadness

1 year ago 5 1 2 0

I was about to text you and @hswapnil.medsky.social about it. Terrible situation

1 year ago 0 0 1 0

🤣🤣 I think some of those votes on zoom were ignored

1 year ago 4 1 1 0
Post image Post image Post image Post image
1 year ago 0 0 0 0
Post image Post image Post image Post image

University of New Mexico division of nephrology #NephMadness fellowship bracket choices

Incremental HD takes the crown 👑

#UNMNephro

@christosargyrop.bsky.social @nephcrit.bsky.social

1 year ago 14 7 2 0

Interested in learning more about the editorial and review process for manuscript submissions? The #AmericanJournalofTransplantation is accepting fellow applications now- see link 👇
www.amjtransplant.com/fellowship [amjtransplant.com]
Accepting applications December 1 - January 15, 2025.

1 year ago 18 7 1 5
Preview
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes | NEJM Effective targets for systolic blood-pressure control in patients with type 2 diabetes are unclear. We enrolled patients 50 years of age or older with type 2 diabetes, elevated systolic blood press...

www.nejm.org/doi/full/10....

1 year ago 0 0 0 0
Advertisement